Peter Laurence Toogood

USPTO Granted Patents = 32 (Patent Applications = 5)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 4.9

ph-index = 11

Forward Citations = 377(Granted Patents)

Company Filing History:

Warner-lambert Company

patents

3 out of 2,405

Merck Sharp + Dohme Corp.

patents

4. 2 out of 3,370

University of Michigan

patents

5. 2 out of 523

Pharmacia & Upjohn Company

9. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2020

Loading Chart...

32 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10556898 - Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease (2020-02-11),

2. 10532088 - Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods (2020-01-14),

3. 10377768 - Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2019-08-13),

4. 10208061 - Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-02-19),

5. 10112935 - Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease (2018-10-30),

6. 9920012 - [object Object] (2018-03-20),

7. 9802958 - Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease (2017-10-31),

8. 9657033 - Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease (2017-05-23),

9. 9580391 - [object Object] (2017-02-28),

10. 9512111 - N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease (2016-12-06),

11. 9394315 - Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2016-07-19),

12. 9266827 - Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease (2016-02-23),

13. 9221814 - [object Object] (2015-12-29),

14. 9169199 - [object Object] (2015-10-27),

15. 8952149 - Tricyclic tetrahydroquinoline antibacterial agents (2015-02-10),

Title: The Innovative Mind of Peter Laurence Toogood

Introduction:

Peter Laurence Toogood, a distinguished inventor based in Ann Arbor, MI, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Peter Toogood's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles and innovative solutions for renewable energy storage systems.

Career Highlights:

With a career spanning over two decades, Peter Toogood has established himself as a visionary in the tech industry. His work has revolutionized various sectors, from healthcare to transportation, earning him multiple accolades and patents along the way.

Collaborations:

Throughout his career, Peter Toogood has collaborated with leading research institutions, top universities, and prominent tech companies to bring his innovative ideas to life. His ability to work across disciplines has led to the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion:

In conclusion, Peter Laurence Toogood's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.